Analystreport

Bio-Rad Laboratories, Inc. (NYSE: BIO) is now covered by analysts at Goldman Sachs Group Inc. They set a "buy" rating on the stock.

Bio-Rad Laboratories, Inc. Class A  (BIO) 
Last bio-rad laboratories, inc. class a earnings: 2/13 04:15 pm Check Earnings Report